Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. 1985

V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate

Confluent cultures of endothelial cells from human umbilical cord were used to study the effect of activated human protein C (APC) on the production of plasminogen activators, plasminogen activator-inhibitor, and factor VIII-related antigen. Addition of APC to the cells in a serum-free medium did not affect the production of tissue-type plasminogen activator (t-PA) or factor VIII-related antigen; under all measured conditions, no urokinase activity was found. However, less plasminogen activator-inhibitor activity accumulated in the conditioned medium in the presence of APC. This decrease was dose dependent and could be prevented by specific anti-protein C antibodies. No decrease was observed with the zymogen protein C or with diisopropylfluorophosphate-inactivated APC. APC also decreased the t-PA inhibitor activity in endothelial cell-conditioned medium in the absence of cells, which suggests that the effect of APC is at least partly due to a direct effect of APC on the plasminogen activator-inhibitor. High concentrations of thrombin-but not of factor Xa or IXa--had a similar effect on the t-PA inhibitor activity. The effect of APC on the plasminogen activator-inhibitor provides a new mechanism by which APC may enhance fibrinolysis. The data suggest that activation of the coagulation system may lead to a secondary increase of the fibrinolytic activity by changing the balance between plasminogen activator(s) and its (their) fast-acting inhibitor.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
March 1993, Thrombosis and haemostasis,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
November 1987, Biochemistry,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
March 1998, Human cell,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
November 1989, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
October 2005, Arteriosclerosis, thrombosis, and vascular biology,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
January 2008, Thrombosis research,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
January 1993, Haemostasis,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
January 1996, Polish journal of pharmacology,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
July 1989, Biochemistry,
V W van Hinsbergh, and R M Bertina, and A van Wijngaarden, and N H van Tilburg, and J J Emeis, and F Haverkate
June 1993, Thrombosis research,
Copied contents to your clipboard!